论文部分内容阅读
目的研究分析小儿肺炎继发腹泻的相关因素,并探讨微生态制剂对该病的干预作用。方法选取该院2013年1月-2014年1月收治的肺炎继发腹泻患儿60例为研究对象,随机分为观察组与对照组,各30例。对照组进行乳酶生片治疗,观察组进行微生态制剂治疗,对比两组患者临床效果,分析继发腹泻的相关因素。结果观察组患者治疗有效率、满意度明显高于对照组,两组比较差异有统计学意义(P<0.05)。患儿年龄、住院时间、是否有入侵性操作、使用抗生素和激素≥2周均与小儿出现继发性腹泻有关。结论在肺炎继发腹泻患儿的治疗过程中进行微生态制剂治疗,能够提高治疗的效果和患者的满意度;患儿年龄越小、住院时间越长、接受入侵性操作等相关因素均能增加患儿出现继发腹泻的发生率。
Objective To study the related factors of secondary diarrhea in children with pneumonia and to explore the intervention effect of probiotics on this disease. Methods Sixty children with pneumonia secondary diarrhea treated in our hospital from January 2013 to January 2014 were selected as study subjects and randomly divided into observation group and control group with 30 cases in each group. The control group was treated with lactase green sheets, and the observation group was treated with probiotics. The clinical effects were compared between the two groups, and the related factors of secondary diarrhea were analyzed. Results The effective rate and satisfaction of the observation group were significantly higher than those of the control group, the difference was statistically significant (P <0.05). Children’s age, length of stay, whether there is invasive operation, the use of antibiotics and hormones ≥ 2 weeks are associated with secondary diarrhea in children. Conclusions The treatment of probiotics in the treatment of children with secondary diarrhea of pneumonia can improve the effect of treatment and the satisfaction of the patients. The younger the patients, the longer the hospitalization time, the more invasive factors such as operation can be increased Children with secondary diarrhea incidence.